Market Alert: Trump’s Tariff Policy Pressures Healthcare Stocks
Micro-X Ltd (ASX:MX1), has announced an AU$3.3 million purchase order for its Rover Plus Mobile DR X-ray units from its newly appointed Malaysian distributor, Integrated Medical System Sdn Bhd (IMS). The units will be supplied to the Malaysian Ministry of Health, marking the company’s first major order in Southeast Asia and a key milestone in its regional expansion. Deliveries are scheduled to commence in October 2025 and continue through the first half of FY2026.
The order follows the successful registration of Rover Plus in Malaysia and Vietnam, paving the way for new opportunities across Southeast Asia. IMS, with a strong track record in medical technology distribution, secured the tender and will support deployment across Ministry-run healthcare facilities. The Rover Plus, powered by Micro-X’s NEX Technology, offers lightweight, hospital-grade imaging with high mobility, instant start-up, and low servicing needs, making it an ideal solution for diverse healthcare environments.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com
Oct 03, 2025
Oct 03, 2025
Oct 03, 2025
Oct 03, 2025
Oct 03, 2025
Oct 03, 2025
Oct 03, 2025
Oct 03, 2025
Oct 02, 2025
Oct 02, 2025
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.